Abiopharma

🔍 Karp Alexander C. (Director)

Company: Palantir Technologies Inc. (PLTR)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 402,348 shares of Class A Common Stock (Direct)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | shares_owned_after: 6,834,606.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 11,378 shares of Class A Common Stock at $172.6542 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,823,228.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 19,493 shares of Class A Common Stock at $173.7864 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,803,735.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 306,544 shares of Class A Common Stock at $174.8455 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,497,191.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 63,629 shares of Class A Common Stock at $175.4185 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,433,562.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,304 shares of Class A Common Stock at $176.3133 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,432,258.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Acquired 90,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | shares_owned_after: 6,522,258.00 | transaction_form_type: 4 | Footnotes: F8, F2
• Sold 4,200 shares of Class A Common Stock at $172.6597 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,518,058.00 | transaction_form_type: 4 | Footnotes: F8, F9
• Sold 11,602 shares of Class A Common Stock at $173.845 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,506,456.00 | transaction_form_type: 4 | Footnotes: F8, F10
• Sold 62,498 shares of Class A Common Stock at $174.7299 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,443,958.00 | transaction_form_type: 4 | Footnotes: F8, F11
• Sold 11,200 shares of Class A Common Stock at $175.4821 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,432,758.00 | transaction_form_type: 4 | Footnotes: F8, F12
• Sold 500 shares of Class A Common Stock at $176.302 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,432,258.00 | transaction_form_type: 4 | Footnotes: F8, F13
• Sold 877,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2031-05-20 | equity_swap_involved: 0 | shares_owned_after: 16,672,500.00 | transaction_form_type: 4 | Footnotes: F14, F1, F15, F2
• Acquired 877,500 shares of Class B Common Stock (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 52,887,749.00 | transaction_form_type: 4 | Footnotes: F2, F2, F1, F2, F2
• Sold 97,500 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2031-05-20 | equity_swap_involved: 0 | shares_owned_after: 1,852,500.00 | transaction_form_type: 4 | Footnotes: F16, F1, F15, F2
• Acquired 97,500 shares of Class B Common Stock (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 52,985,249.00 | transaction_form_type: 4 | Footnotes: F2, F2, F1, F2, F2
• Sold 402,348 shares of Class B Common Stock (Derivative)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | shares_owned_after: 52,582,901.00 | transaction_form_type: 4 | Footnotes: F2, F2, F1, F2, F2
• Sold 90,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-20 | Code: C | equity_swap_involved: 0 | shares_owned_after: 52,492,901.00 | transaction_form_type: 4 | Footnotes: F2, F2, F8, F2, F2

Footnotes:

• F1: This transaction is part of a related series of transactions. The Reporting Person acquired rights to 975,000 shares of Class B Common Stock upon incremental vesting of previously granted restricted stock units ("RSUs") on August 20, 2026, converted 402,348 shares of the Class B Common Stock to Class A Common Stock and immediately sold the resulting shares of Class A Common Stock on August 20, 2026. All sales were automatic sales of shares to cover required tax withholding obligations in connection with the vesting event on August 20, 2026 and were conducted in compliance with the Reporting Person's Rule 10b5-1 trading plan.
• F2: The Class B Common Stock is convertible into the Issuer's Class A Common Stock on a 1-for-1 basis and has no expiration date.
• F3: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $172.19 to $173.13. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $173.21 to $174.20. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $174.21 to $175.208. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F6: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $175.21 to $176.19. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F7: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $176.28 to $176.37. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (3) through (7) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F8: This transaction is part of a related series of transactions undertaken on August 20, 2026 pursuant to a preexisting Rule 10b5-1 trading plan, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on March 12, 2026. The Reporting Person converted 90,000 shares of Class B Common Stock to Class A Common Stock and immediately sold the resulting shares of Class A Common Stock in the open market.
• F9: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $172.19 to $173.09. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (9) through (13) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F10: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $173.21 to $174.20. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (9) through (13) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F11: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $174.21 to $175.20. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (9) through (13) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F12: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $175.21 to $176.18. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (9) through (13) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F13: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $176.26 to $176.33. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (9) through (13) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F14: These securities are RSUs granted pursuant to the Issuer's Amended 2010 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock.
• F15: The shares acquired from the incremental vesting of RSUs (as described above) were fully vested as of the transaction date.
• F16: These securities are RSUs granted pursuant to the Issuer's 2020 Executive Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock.
• REMARKS: Officer title: Chief Executive Officer. This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person. For additional details regarding the Reporting Person's overall stock and equity holdings, please see the Issuer's Proxy Statement filed with the Securities and Exchange Commission on April 24, 2026, including under the heading "Security Ownership Of Certain Beneficial Owners And Management" (subject to the definitions, explanations, and time periods described therein).